Literature DB >> 29865075

Effects of a 3-Year Multi-Domain Intervention with or without Omega-3 Supplementation on Cognitive Functions in Older Subjects with Increased CAIDE Dementia Scores.

Jagadish K Chhetri1,2,3, Philipe de Souto Barreto1, Christelle Cantet1,4, Kristell Pothier1, Matteo Cesari1,4,5,6, Sandrine Andrieu4,5, Nicola Coley4,5, Bruno Vellas1,4,5.   

Abstract

Findings from recent Alzheimer's disease prevention trials have shown subjects with increased dementia score based upon mid-life cardiovascular risk factors, to benefit from multi-domain intervention strategies to some extent. The effects of such interventions on cognitive functions remains yet to be well-established. This study is a secondary analysis of the MAPT study, 1,293 older subjects (mean age 75 years) with high CAIDE score (i.e., ≥6) were classified according to the four intervention groups: 1) multi-domain intervention plus placebo, 2) isolated supplementation with Omega-3 polyunsaturated fatty acid (n-3 PUFA), 3) combination of the two interventions, and 4) placebo alone. Linear mixed-model repeated-measures analyses were used to assess the cognitive changes according to various neuropsychological test scores between intervention groups compared to the placebo at 36 months from baseline. Compared to the placebo, group with multi-domain intervention in combination withn-3PUFA was found to show significant improvement in the delayed total recall test of the free and cued selective reminding test (FCSRT) (mean±standard error(SE) = 0.20±0.10) and MMSE orientation test (mean±SE = 0.15±0.06) at 36 months. Isolated multi-domain intervention group showed significant less decline in the MMSE orientation test (mean±SE = 0.12±0.06) compared to the placebo. There was significant less improvement (mean±SE = - 1.01±0.46) in the FCSRT free recall test in the n-3 PUFA intervention group compared to the placebo at 36 months. Our findings show high-risk subjects for dementia screened with CAIDE dementia score might benefit from multi-domain intervention strategies as in the MAPT study, particularly in the orientation and delayed recall domain.

Entities:  

Keywords:  Alzheimer’s disease; CAIDE; MAPT study; cognitive decline; cognitive functions; multi-domain intervention; n-3 PUFA; neuropsychological tests; omega-3; prevention

Mesh:

Substances:

Year:  2018        PMID: 29865075     DOI: 10.3233/JAD-180209

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  24 in total

Review 1.  Nutrition, Physical Activity, and Other Lifestyle Factors in the Prevention of Cognitive Decline and Dementia.

Authors:  Ligia J Dominguez; Nicola Veronese; Laura Vernuccio; Giuseppina Catanese; Flora Inzerillo; Giuseppe Salemi; Mario Barbagallo
Journal:  Nutrients       Date:  2021-11-15       Impact factor: 5.717

2.  Impact of Multidomain Lifestyle Intervention on Cerebral Cortical Thickness and Serum Brain-Derived Neurotrophic Factor: the SUPERBRAIN Exploratory Sub-study.

Authors:  So Young Moon; Sohui Kim; Seong Hye Choi; Chang Hyung Hong; Yoo Kyoung Park; Hae Ri Na; Hong-Sun Song; Hee Kyung Park; Muncheong Choi; Sun Min Lee; Buong-O Chun; Jong-Min Lee; Jee Hyang Jeong
Journal:  Neurotherapeutics       Date:  2022-08-01       Impact factor: 6.088

3.  Alzheimer Disease: Standard of Diagnosis, Treatment, Care, and Prevention.

Authors:  Stefan Teipel; Deborah Gustafson; Rik Ossenkoppele; Oskar Hansson; Claudio Babiloni; Michael Wagner; Steffi G Riedel-Heller; Ingo Kilimann; Yi Tang
Journal:  J Nucl Med       Date:  2022-02-10       Impact factor: 11.082

Review 4.  Multi-domain interventions for the prevention of dementia and cognitive decline.

Authors:  Melanie Hafdi; Marieke P Hoevenaar-Blom; Edo Richard
Journal:  Cochrane Database Syst Rev       Date:  2021-11-08

5.  Preventing Cognitive Decline in Black Individuals With Mild Cognitive Impairment: A Randomized Clinical Trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Benjamin Leiby
Journal:  JAMA Neurol       Date:  2018-12-01       Impact factor: 18.302

Review 6.  New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease.

Authors:  Feng Zhang; Ru-Jia Zhong; Cheng Cheng; Song Li; Wei-Dong Le
Journal:  Acta Pharmacol Sin       Date:  2020-12-02       Impact factor: 7.169

7.  Non-Amyloid Approaches to Disease Modification for Alzheimer's Disease: An EU/US CTAD Task Force Report.

Authors:  Serge Gauthier; P S Aisen; J Cummings; M J Detke; F M Longo; R Raman; M Sabbagh; L Schneider; R Tanzi; P Tariot; M Weiner; J Touchon; B Vellas
Journal:  J Prev Alzheimers Dis       Date:  2020-04-06

8.  The Barcelona Brain Health Initiative: A Cohort Study to Define and Promote Determinants of Brain Health.

Authors:  Gabriele Cattaneo; David Bartrés-Faz; Timothy P Morris; Javier Solana Sánchez; Dídac Macià; Clara Tarrero; Josep M Tormos; Alvaro Pascual-Leone
Journal:  Front Aging Neurosci       Date:  2018-10-11       Impact factor: 5.750

9.  Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer's Association Reserve, Resilience and Protective Factors Professional Interest Area working groups.

Authors:  Robert Perneczky; Gerd Kempermann; Amos D Korczyn; Fiona E Matthews; M Arfan Ikram; Nikolaos Scarmeas; Gael Chetelat; Yaakov Stern; Michael Ewers
Journal:  BMC Med       Date:  2019-02-27       Impact factor: 8.775

10.  Cardio-Dance Exercise to Improve Cognition and Mood in Older African Americans: A Propensity-Matched Cohort Study.

Authors:  Bernadette A Fausto; Solaleh Azimipour; Lisa Charles; Christina Yarborough; Keyla Grullon; Emily Hokett; Paul R Duberstein; Mark A Gluck
Journal:  J Appl Gerontol       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.